Narmada Gelatines Limited (SHAWGELTIN) Fair Value & Analysis
Basic Materials · IN · Market cap ₹3.1B
Fair value as of: Jul 6, 2026
From 26 valuation models · updated today
Share price +0.1% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹329.42 – ₹509.95 · fair‑value band ₹471.16 – ₹1,106 · the ₹505.15 price screens below the ₹831.75 fair value. As of Jul 6, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Narmada Gelatines Limited (SHAWGELTIN) currently trades at ₹505.15, while our model-based Fair Value estimate is ₹831.75 — implying the stock looks roughly 64.7% undervalued today. We read business quality at 74/100 (solid quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Narmada Gelatines Limited generated revenue of ₹2.2B at a net margin of 14.6%. Revenue grew 24.0% year over year. It earns a return on equity of 23.7%. Net debt stands at ₹77.8M. Fundamentals as of Jul 6, 2026
Our scenario range runs from ₹471.16 (bear case) to ₹1,106 (bull case); at ₹505.15, the current price sits within that range. The share trades about 5% below its 52-week high and 57% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -66% fair-value upside — at 65%, SHAWGELTIN screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.
About the company
Narmada Gelatines Limited manufactures and sells gelatine and related products in India and internationally. The company's products include ossein and di-calcium phosphate. It serves food and beverage, pharmaceutical, photography, biomedical, personal care, and other technical industries. The company was formerly known as Shaw Wallace Gelatines Ltd. and changed its name to Narmada Gelatines Limited in 2002. Narmada Gelatines Limited was incorporated in 1961 and is based in Jabalpur, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Narmada Gelatines Limited reported revenue of ₹2.2B in FY2026 versus ₹1.6B in FY2022, a compound +8.2%/yr. Reported net income was ₹315M in FY2026, compounding +26.4%/yr from FY2022.
Is SHAWGELTIN fairly valued? → Check now
Similar stocks
10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 6, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Linde plc LIN | $507.90 | $142.21 | -72% |
| L'Air Liquide S.A AIQUY | $38.20 | $13.08 | -66% |
| Air Products and Chemicals, Inc A1PD34 | R$360.05 | R$174.71 | -51% |
| Intercontinental Exchange, Inc I1CE34 | R$367.00 | R$311.38 | -15% |
| Wanhua Chemical Group 600309 | ¥67.90 | ¥46.52 | -31% |
| Asian Paints Limited ASIANPAINT | ₹2,687 | ₹655.71 | -76% |
| Nan Ya Plastics Corporation 1303 | 154.50 TWD | 7.80 TWD | -95% |
| PPG Industries, Inc PPG | 1,988 MXN | 68.53 MXN | -97% |
| LyondellBasell Industries N.V L1YB34 | R$171.50 | R$190.25 | +11% |
| Solar Industries India Limited SOLARINDS | ₹18,441 | ₹4,083 | -78% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Narmada Gelatines Limited (SHAWGELTIN) undervalued?
What is the fair value of SHAWGELTIN?
What is the quality score of SHAWGELTIN?
What is the revenue of Narmada Gelatines Limited (SHAWGELTIN)?
What is the net profit margin of SHAWGELTIN?
Does Narmada Gelatines Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.